Dogu, Figen <br/><br/>
CD40 ligand deficiency with grade III liver fibrosis, transplanted by a treosulphan-based conditioning regimen.  [electronic resource] 

 -  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation  Oct 2011 
 - 349-52 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2146-8427 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biopsy<br/>Bone Marrow Transplantation--adverse effects<br/>Busulfan--adverse effects<br/>CD40 Ligand--deficiency<br/>Child, Preschool<br/>Cyclophosphamide--therapeutic use<br/>Histocompatibility Testing<br/>Humans<br/>Hyper-IgM Immunodeficiency Syndrome, Type 1--immunology<br/>Liver Cirrhosis--immunology<br/>Male<br/>Myeloablative Agonists--adverse effects<br/>Severity of Illness Index<br/>Time Factors<br/>Transplantation Conditioning--adverse effects<br/>Treatment Outcome